These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35289361)

  • 1. Inhibition of azole-resistant Aspergillus fumigatus biofilm at various formation stages by antifungal drugs, including olorofim.
    Kirchhoff L; Dittmer S; Furnica DT; Buer J; Steinmann E; Rath PM; Steinmann J
    J Antimicrob Chemother; 2022 May; 77(6):1645-1654. PubMed ID: 35289361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of olorofim against Aspergillus fumigatus sensu lato clinical isolates: activity is retained against isolates showing resistance to azoles and/or amphotericin B.
    Escribano P; Gómez A; Reigadas E; Muñoz P; Guinea J;
    Clin Microbiol Infect; 2022 Sep; 28(9):1291.e7-1291.e10. PubMed ID: 35597509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiofilm activity of antifungal drugs, including the novel drug olorofim, against Lomentospora prolificans.
    Kirchhoff L; Dittmer S; Weisner AK; Buer J; Rath PM; Steinmann J
    J Antimicrob Chemother; 2020 Aug; 75(8):2133-2140. PubMed ID: 32386411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Itraconazole and Micafungin on Aspergillus fumigatus Biofilms.
    Liu M; Zheng H; Zeng R; Liang G; Zheng N; Liu W
    Mycopathologia; 2021 Jun; 186(3):387-397. PubMed ID: 33956291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of olorofim against 507 filamentous fungi including antifungal drug-resistant strains at a tertiary laboratory in Australia: 2020-2023.
    Halliday CL; Tay E; Green W; Law D; Lopez R; Faris S; Meehan L; Harvey E; Birch M; Chen SCA
    J Antimicrob Chemother; 2024 Oct; 79(10):2611-2621. PubMed ID: 39105545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity.
    Rajendran R; Mowat E; McCulloch E; Lappin DF; Jones B; Lang S; Majithiya JB; Warn P; Williams C; Ramage G
    Antimicrob Agents Chemother; 2011 May; 55(5):2092-7. PubMed ID: 21321135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms.
    Rajendran R; Mowat E; Jones B; Williams C; Ramage G
    Int J Antimicrob Agents; 2015 Sep; 46(3):342-5. PubMed ID: 25979638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,5-Dicaffeoylquinic Acid Disperses Aspergillus Fumigatus Biofilm and Enhances Fungicidal Efficacy of Voriconazole and Amphotericin B.
    Luo J; Wang K; Li GS; Lei DQ; Huang YJ; Li WD; Chen YQ; Kong JL
    Med Sci Monit; 2018 Jan; 24():427-437. PubMed ID: 29356802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
    Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
    Buil JB; Rijs AJMM; Meis JF; Birch M; Law D; Melchers WJG; Verweij PE
    J Antimicrob Chemother; 2017 Sep; 72(9):2548-2552. PubMed ID: 28605488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Allyl-2-methoxyphenol modulates the expression of genes involved in efflux pump, biofilm formation and sterol biosynthesis in azole resistant
    Sen P; Gupta L; Vijay M; Vermani Sarin M; Shankar J; Hameed S; Vijayaraghavan P
    Front Cell Infect Microbiol; 2023; 13():1103957. PubMed ID: 36816579
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Talbot JJ; Frisvad JC; Meis JF; Hagen F; Verweij PE; Hibbs DE; Lai F; Groundwater PW; Samson RA; Kidd SE; Barrs VR; Houbraken J
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of azole resistance in Aspergillus fumigatus complex in New Zealand.
    McKinney WP; Vesty A; Sood J; Bhally H; Morris AJ
    N Z Med J; 2021 Jun; 134(1536):41-51. PubMed ID: 34140712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
    Mowat E; Lang S; Williams C; McCulloch E; Jones B; Ramage G
    J Antimicrob Chemother; 2008 Dec; 62(6):1281-4. PubMed ID: 18819968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
    Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
    Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus.
    Kirchhoff L; Dittmer S; Buer J; Rath PM; Steinmann J
    Int J Antimicrob Agents; 2020 Sep; 56(3):106105. PubMed ID: 32721601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal and antibiofilm activities of auranofin against itraconazole-resistant Aspergillus fumigatus.
    Chen P; Yang J; Jin Y; Lu C; Feng Z; Gao F; Chen Y; Wang F; Shang Z; Lin W
    J Mycol Med; 2023 May; 33(2):101381. PubMed ID: 37037064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
    Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
    J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance profiling of
    Buil JB; Oliver JD; Law D; Baltussen T; Zoll J; Hokken MWJ; Tehupeiory-Kooreman M; Melchers WJG; Birch M; Verweij PE
    Emerg Microbes Infect; 2022 Dec; 11(1):703-714. PubMed ID: 35109772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of azole resistant-
    Danion F; Duréault A; Gautier C; Senechal A; Persat F; Bougnoux ME; Givel C; Couderc LJ; Lortholary O; Garcia-Hermoso D; Lanternier F
    J Med Microbiol; 2020 Jun; 69(6):844-849. PubMed ID: 32459615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.